RONNIE R. MCMILLAN 5832 Dapple Trace Indianapolis, IN 46228 317.459.7535 http://www.linkedin.com/in/rrmcmillan rm17be93c@westpost.

net SUMMARY Healthcare marketing professional with 12 plus years of pharmaceutical, consumer products, and medical device sales and marketing experience, with proven result s. Forged top producing and profitable partnerships, awarded for marketing and sales excellence, led high performing teams and developed business strategies to ward building multi-billion dollar brands. Builds trust and strong relationship s with internal and external stakeholders and has excellent agency management sk ills. Has a marketing and research background in Neurology, Oncology, and Diabe tes that gives a competitive edge and the ability to produce clinically relevant and strategically sound marketing campaigns. PROFESSIONAL EXPERIENCE Strategic Marketing Advisor 3/2010-present Serve as an advisor for the Coleman Research Group to help their clients better understand the market dynamics, industry trends and competitive landscape of th e pharmaceutical and biotechnology industries Advise marketing personnel on sales and patient segmentation techniques, based on extensive rounds of market research that have been completed with physicians and consumers ELI LILLY AND COMPANY 2010 Educational Leave to pursue MBA 8/1998 - 3/ (1/2008 - 3/2010)

Marketing Manager-Cymbalta Brand Team* (1/2006 - 1/2008) Helped establish a firm market position during the launch of Cymbalta for Depre ssion and Diabetic Peripheral Neuropathic Pain into a crowded marketplace that t urned it into a $2B brand Increased physician and consumer awareness and brand preference scores for Cymb alta by more than 200% through the development and execution of direct to physic ian and direct to consumer advertising campaigns Crafted and implemented annual strategic marketing and tactical plans which inc luded qualitative and quantitative consumer insights research for a successful t elevision ad campaign Directed a cross functional team that monitored the competitive landscape on a daily basis and addressed competitive issues via the development of press releas es Won Miracle Award for leading the creation and execution of the launch strategy for Cymbalta, which included multiple indications and customer settings, at its first National Sales Meeting Managed a $5M budget within a 1% variance Assoc. Marketing Manager-Neuro Portfolio Team* (11/2004 - 1/2006) Partnered with the Neuroscience Brand Teams to reduce expenses by more than 50% by streamlining all sales and marketing activities for 4 brands and creating me ssaging and branding for them as a portfolio Trained the sales force and marketing organization on how to differentially dia gnose mental health disorders, by partnering with Key Opinion Leaders on the con ception and design of workshops with real patient scenarios using DSM IV criteri a; exit survey data from 1800 sales representatives confirmed that over 90% stro ngly agreed that the Differential Diagnosis platform exceeded its goal and over 85% wanted similar trainings on a quarterly basis, which were given funding by t

he organization Delivered quarterly marketing and sales updates to C-level executives Marketing Associate-Zyprexa Brand Team (12/2003 - 11/2004) Turned around and stabilized Zyprexa after years of declining sales by developi ng marketing campaigns and sales force materials that rekindled interest in the brand and returned it to its top selling $4B status for Lilly with a SOM of 14% Won ~Marketing That Matters Excel Award(tm); developed and launched a new targe t patient strategy and creative for Zyprexa, to focus on its position of strengt h in the marketplace, amidst unusual circumstances (no new budget)-used existing resources to launch the successful campaign in an unconventional way Led extensive rounds of research to test the effectiveness and persuasiveness o f the new campaign Senior Neurology Sales Representative (6/2001 - 12/2003) Top performer achieving $12M+ in sales of Zyprexa and Strattera by calling on a nd developing relationships with psychiatrists in hospitals, community mental he alth centers, and private practice offices Produced consistent top 25% results and above 100% actual vs. quota performanc e for the portfolio Improved territory performance ranking from 247/250 to 27/250 Voted to Sales Director(tm)s Council for exemplary leadership, sales performanc e, and attitude Partnered with customers and Key Opinion Leaders to gain formulary acceptance f or the portfolio of products at managed care organizations and on hospital formu laries Chosen as the Zyprexa Champion and sales consultant to the Zyprexa Brand team Specialty Sales Representative (8/1998 - 6/2001) Top performer selling Zyprexa and Prozac to hospitals and office based clinicia ns Achieved $5,000,000+ in sales annually by developing relationships with and tar geting key customers Consistent top 25% results (actual vs. quota) for the portfolio of products Awarded for growing Prozac SOM by 25% in the final year of its life cycle Chosen as a mentor to several new sales representatives PROFESSIONAL DEVELOPMENT Sales Director(tm)s Council Voted to Sales Director(tm)s Council for exemplary leadership, sales performance , and attitude. Developed sales techniques, marketing strategies and provided d irection to the sales organization on implementation. College Relations for Eli Lilly(tm)s Diversity Council (Hampton and Virginia Tec h Universities) Campus recruiting for Lilly which included the selection, screening, and develop ment of new sales representatives of diverse backgrounds to help create a more s upportive corporate culture for diverse talent Zyprexa Marketing Team Chosen to represent the sales force by acting as a consultant to the marketing t eams on the development, market research testing, and execution of all marketing materials designed for the sales organization INTERNSHIP EXPERIENCE Roche Diagnostics Corporation

Conducted market research to determine the evolution of the ACCU-CHEK(R) Brand diabetes behavior change platform and make final recommendations to the Brand te am Assessed the qualitative and quantitative impact of these behavior change initi atives on the overall business The final recommendations were given an exemplary rating and the platform given funding for two years Kraft Foods Sold Kraft Foods(tm) portfolio of products including Kool-Aid, Kraft Cheese, an d Maxwell House brands to wholesalers and retail stores, managed territories, an d maintained business relationships with customers Conducted market research to gain a comprehensive understanding of the sales po tential of Kraft Foods(tm) newest portfolio of products and those of its competi tors, presented findings to C-level executives EDUCATION & TRAINING Indiana University Kelley School of Business M.B.A. Marketing Hampton University 05/1998 Bachelor of Science in Marketing Magna Cum Laude Graduate All-American Scholar 12/2009